Pharma BD Deal Intelligence

Pfizer Inc. / Esperion Therapeutics Inc.

2003 · Acquisition/Merger · $1.3B · Complete

Pfizer agreed to acquire Esperion Therapeutics for ~$1.3B ($35/share, a 54% premium) to add the HDL/cardiovascular asset ETC-216; announced Dec 21, 2003 and closed Feb 10, 2004.

Key facts

• Announced Dec 21, 2003
• Deal value $1.3B
• Deal type Acquisition/Merger

← Browse all deals  ·  How we score deals